Nebula Research & Development’s Elevance Health ELV Stock Holding History

Nebula Research & Development’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,666	Closed	-$725K	–	1009
2025 Q1	$725K	Sell	1,666 -3,547	-68%	-$1.42M	0.07%	481
2024 Q4	$1.92M	Buy	5,213 +4,395	+537%	+$1.84M	0.23%	115
2024 Q3	$425K	Sell	818 -570	-41%	-$305K	0.05%	596
2024 Q2	$752K	Buy	1,388 +625	+82%	+$330K	0.12%	300
2024 Q1	$396K	Buy	+763	New	+$379K	0.09%	433
2023 Q3	–	Sell	-1,417	Closed	-$630K	–	544
2023 Q2	$630K	Buy	+1,417	New	+$654K	0.48%	19

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Nebula Research & Development's ELV Position: Q2 2025 in Review

Nebula Research & Development sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,666 shares — an estimated $725K sold.

Nebula Research & Development first reported a position in ELV in Q2 2023 and held it in 6 quarters. The position peaked at $1.92M in Q4 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Nebula Research & Development reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Nebula Research & Development sold 1,666 Elevance Health shares in Q2 2025, an estimated $725K.
Nebula Research & Development first reported a position in Elevance Health in Q2 2023 and held it in 6 quarters.
Nebula Research & Development's Elevance Health position peaked at $1.92M in Q4 2024.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.